| For: | de Ruiter PE, Gadjradj Y, de Knegt RJ, Metselaar HJ, Ijzermans JN, van der Laan LJ. Interaction of immunosuppressants with HCV antivirals daclatasvir and asunaprevir: combined effects with mycophenolic acid. World J Transplantation 2018; 8(5): 156-166 [PMID: 30211024 DOI: 10.5500/wjt.v8.i5.156] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3230/full/v8/i5/156.htm |
| Number | Citing Articles |
| 1 |
Leandro S. de Mariz e Miranda. The synergy between nucleotide biosynthesis inhibitors and antiviral nucleosides: New opportunities against viral infections?. Archiv der Pharmazie 2023; 356(1) doi: 10.1002/ardp.202200217
|
| 2 |
Shayan Majidifar, Mohsen Hooshmand. VCTatDot and VCTatMLP: novel deep learning models with triadic attention embeddings for synergistic drug combination prediction. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-19200-6
|
| 3 |
Khalid Al-Naaman, Siham Al-Sinani. Direct-Acting Antivirals against Hepatitis C. 2026; doi: 10.1016/B978-0-443-41363-6.00010-X
|
| 4 |
Claudia Soledad Sepúlveda, Cybele Carina García, Elsa Beatriz Damonte. Inhibitors of Nucleotide Biosynthesis as Candidates for a Wide Spectrum of Antiviral Chemotherapy. Microorganisms 2022; 10(8) doi: 10.3390/microorganisms10081631
|